No insider purchase over the last 90 days. The latest was filed 29 Dec 2025.
This page follows insider dealings at ImageneBio, Inc. as filed with SEC (Form 4). 5 insiders have disclosed 10 filings since 18 October 2025.
The record shows 1 purchase on the open market worth €81k, made by 1 insider, against 2 sales worth €15k by 1 insider. On balance, insiders were net buyers of €66k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Biggest ticket of the year: €81k, bought by Slattery Joseph P and made public on 29 December 2025. On the buying side, the filings list 1 senior executive among the declarants.
For context, the typical company on the same exchange (median of 5,458 companies) published 22 filings over the same period, against 10 filings here. Since 2021, the database holds 3 purchases and 2 sales by insiders of the company.
The latest purchase dates back some time: it was published 293 days ago, on 29 December 2025. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
For comparison within the same market, see the insider buying recorded at GameStop Corp. and Heico Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2025 · cache
Same trade as the filing by Orbimed Advisors LLC, counted once · View ↗
25 of 28 declarations
ImageneBio, Inc. is a company focused on developing gene therapies for cancer treatment. It is listed on the XNAS market.
Purchases our model currently ranks for the recommendations list.
All recommendations